By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Syrian Arab News Agency (SANA)
  • Latest News
  • Syria
  • Middle East
  • Economy
  • Politics
  • Sport
  • International
Reading: AI-designed coronavirus vaccine shows promise in early human trial
  • AR
  • TR
  • FR
  • ES
  • KU
  • Culture
  • Video
  • Photos
  • Miscellaneous
Syrian Arab News Agency (SANA)Syrian Arab News Agency (SANA)
  • Latest News
  • Syria
  • Middle East
  • Economy
  • Politics
  • Sport
  • International
Search
  • Latest News
  • News Categories
    • Politics
    • Culture
    • Video
    • Photos
    • Miscellaneous
  • Provinces
  •  Languages
    • العربية
    • Türkçe
    • Français
    • Español
    • Kurdî
Follow US
Syrian Arab News Agency (SANA) > Latest News > Miscellaneous > AI-designed coronavirus vaccine shows promise in early human trial

AI-designed coronavirus vaccine shows promise in early human trial

Published: 2026/06/07 4:36 PM
Updated: 2026/06/07 4:36 PM
AI-designed coronavirus vaccine shows promise in early human trial
AI-designed broad-spectrum coronavirus vaccine

London, June 7 (SANA) Scientists at the University of Cambridge have developed an AI-designed broad-spectrum coronavirus vaccine that demonstrated encouraging safety and immune responses in an early human trial, a development researchers say could strengthen preparedness for future pandemics.

According to ScienceDaily, the vaccine, developed in collaboration with Cambridge-based biotechnology company DIOSynVax, was tested on 39 healthy volunteers. Researchers found that it triggered immune responses against a broad range of coronaviruses, including SARS-CoV-2, the virus that causes COVID-19, SARS and related bat coronaviruses that could pose future pandemic risks.

The researchers said the vaccine is based on a “super antigen” designed entirely using artificial intelligence and machine learning technologies. The AI system analyzed shared genetic features across multiple coronaviruses to identify targets capable of generating broad immune protection against both known viruses and potential future variants.

Professor Jonathan Heeney, who led the study at the University of Cambridge’s Department of Veterinary Medicine, said the approach represents a shift from reactive vaccine development toward proactive protection against entire virus families.

The study found the vaccine to be safe and well tolerated, with no serious side effects reported. However, researchers said larger Phase II clinical trials would be needed to further assess immune responses across more diverse population groups.

Researchers added that the approach could also be used to develop universal vaccines against other viruses, including influenza and Ebola, potentially improving global preparedness for future infectious disease outbreaks.

R.H/Abd

China researchers identify gene that could make rice perennial, boost yields
First clinical trial begins for experimental immunotherapy targeting solid tumors
AI-powered system improves carbon footprint estimates for electronic devices
6.2-Magnitude Earthquake Strikes Off East Timor Coast
Microsoft: Azure cloud service disrupted by fiber cuts in Red Sea
  • press
  • Photos
  • Video
  • Miscellaneous
TAGGED:AICoronavirusCOVID19healthcareUniversityOfCambridge
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Copy Link

Editors Choice

Olabi: UN resolution acknowledges government’s efforts to improve lives of its people

Olabi: UN resolution acknowledges government’s efforts to improve lives of its people

November 19, 2026
Olabi: Israeli violations in southern Syria must stop

Olabi: Israeli violations in southern Syria must stop

November 18, 2026
Saudi Arabia condemns Israeli incursions into Daraa and Quneitra countryside

Saudi Arabia condemns Israeli incursions into Daraa and Quneitra countryside

November 18, 2026
Al-Shaibani meets former US special advisor on Syria Frederic Hof

Al-Shaibani meets former US special advisor on Syria Frederic Hof

November 18, 2026
Syrian Arab News Agency (SANA)

Syrian Arab News Agency – SANA

The official national news agency of Syria, established on June 24, 1965. It is affiliated with the Ministry of Information and headquartered in Damascus.

  • Presidency
  • Politics
  • Syria
  • Economy
  • Health
  • International
  • Education
  • Culture
  • Sport
  • Tour Syria
  • press
  • Photos
  • Video
  • Miscellaneous
© Syrian Arab News Agency. All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?